[Form 4] SSR Mining Inc. Insider Trading Activity

Rhea-AI Filing Summary

IGM Biosciences, Inc. (IGMS) – Form 4 filing dated 07/02/2025

Baker Bros. Advisors LP and affiliated investment funds (667, L.P. and Baker Brothers Life Sciences, L.P.) reported the receipt of 953 fully-vested restricted stock units (RSUs) on 06/30/2025. The RSUs were issued to Felix J. Baker in lieu of a $11,500 board retainer under the company’s Outside Director Compensation Policy. No cash was paid for the shares (price reported as $0).

Post-transaction indirect beneficial ownership stands at

• 357,048 common shares held for the benefit of 667, L.P.
• 3,763,362 common shares held for the benefit of Baker Brothers Life Sciences, L.P.

The Baker entities remain both “10% owners” and directors by deputization of IGMS.

The filing is administrative in nature—reflecting routine director compensation rather than open-market buying or selling—and does not alter the group’s sizable strategic stake in the company.

Insights

Financial Analyst

TL;DR: Routine RSU grant; total Baker Bros. stake unchanged—neutral for valuation.

This Form 4 records a small, non-cash grant of 953 RSUs to Felix Baker for board service, leaving the Baker complex with roughly 4.1 million IGMS shares across two funds. Because the shares were issued in lieu of director fees at no cost, there is no signal of incremental insider buying pressure or fundamental change in conviction. The group’s >10 % ownership and board influence remain intact, underscoring long-term alignment but providing no new catalyst.

Corporate Governance Specialist

TL;DR: Filing confirms compliance with Section 16; immaterial transaction.

The disclosure demonstrates proper reporting of director compensation under Section 16 rules. All parties explicitly disclaim beneficial ownership beyond their pecuniary interests, highlighting robust governance procedures. Material impact is negligible, yet continued transparency from a large shareholder is positive for investors’ trust.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Swager Karen A

(Last) (First) (Middle)

6900 E LAYTON AVE

SUITE 1300

(Street)

DENVER CO 80237

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SSR MINING INC. [ SSRM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Share Unit	(1)	07/01/2025		A		1,768		(1)	(1)	Common Shares	1,768	$0	65,698	D

Explanation of Responses:

1. Each deferred share unit ("DSU") represents the right to receive the cash value of a Common Share of the Issuer at the time of settlement. DSUs are earned upon grant and settled upon the Reporting Person's retirement from the Issuer's Board of Directors.

Remarks:

	/s/ Jasmine Miller, attorney-in-fact for Karen Swager	07/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.